Results 131 to 140 of about 17,302 (187)

Complement C3 is downregulated following ranibizumab intervention in experimental central retinal vein occlusion. [PDF]

open access: yesMol Vis
Cehofski LJ   +8 more
europepmc   +1 more source

Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility. [PDF]

open access: yesOphthalmol Sci
Park SS   +14 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

The Management of Central Retinal Vein Occlusion

Ophthalmology, 1983
Central retinal vein occlusion is the result of outflow obstruction and is associated with a variety of medical conditions, mainly affecting the vascular system. Treatment of the coexistent medical conditions has no beneficial effect on visual outcome.
Eva M Kohner   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy